Literature DB >> 23040867

Serum glycated albumin predicts the progression of carotid arterial atherosclerosis.

Sun Ok Song1, Kwang Joon Kim, Byung-Wan Lee, Eun Seok Kang, Bong Soo Cha, Hyun Chul Lee.   

Abstract

INTRODUCTION: We investigated the association between the ratio of serum glycated albumin (GA) levels to hyperglycemic levels (GA/A1c ratio) and the progression of carotid artery atherosclerosis.
METHODS: For this retrospective longitudinal study we recruited patients who had undergone carotid IMT measurement twice and been tested consecutively for both A1c and GA levels every 3 or 6 months. The subjects were classified into two groups based on non-progression (group I) and progression (group II) of carotid IMT. Mean values of A1c and GA and the GA/A1c ratio were compared between groups.
RESULTS: Of the 218 subjects (122 men and 96 women), group II (n=77) showed significantly higher baseline systolic BP, eGFR, GA, GA/A1c ratio, and progression of carotid IMT (Δ IMT) than group I (n = 141). The mean A1c level tended to be higher in group II than in group I (p = 0.054). By Spearman's correlation test, baseline diastolic BP, total cholesterol, triglyceride, GA, and GA/A1c were significantly associated with Δ IMT in group II but not in group I. In multivariate regression analysis, serum level of GA and GA/HbA1c ratio predicted progression of IMT after adjustment for other risk factors in both models applied.
CONCLUSION: We suggest that glycated albumin is not only a useful glycemic index but also might be an atherogenic protein in the development of diabetic atherosclerosis.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23040867     DOI: 10.1016/j.atherosclerosis.2012.09.005

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  21 in total

Review 1.  Metrics Beyond Hemoglobin A1C in Diabetes Management: Time in Range, Hypoglycemia, and Other Parameters.

Authors:  Lorena Alarcon-Casas Wright; Irl B Hirsch
Journal:  Diabetes Technol Ther       Date:  2017-05       Impact factor: 6.118

2.  Glycated Albumin and Risk of Mortality in the US Adult Population.

Authors:  Mary R Rooney; Natalie Daya; Olive Tang; John William McEvoy; Josef Coresh; Robert H Christenson; Elizabeth Selvin
Journal:  Clin Chem       Date:  2022-03-04       Impact factor: 8.327

Review 3.  Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management.

Authors:  Christina M Parrinello; Elizabeth Selvin
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

Review 4.  Review of methods for detecting glycemic disorders.

Authors:  Michael Bergman; Muhammad Abdul-Ghani; Ralph A DeFronzo; Melania Manco; Giorgio Sesti; Teresa Vanessa Fiorentino; Antonio Ceriello; Mary Rhee; Lawrence S Phillips; Stephanie Chung; Celeste Cravalho; Ram Jagannathan; Louis Monnier; Claude Colette; David Owens; Cristina Bianchi; Stefano Del Prato; Mariana P Monteiro; João Sérgio Neves; Jose Luiz Medina; Maria Paula Macedo; Rogério Tavares Ribeiro; João Filipe Raposo; Brenda Dorcely; Nouran Ibrahim; Martin Buysschaert
Journal:  Diabetes Res Clin Pract       Date:  2020-06-01       Impact factor: 5.602

5.  Association of hemoglobin A1c and glycated albumin with carotid atherosclerosis in community-dwelling Japanese subjects: the Hisayama Study.

Authors:  Naoko Mukai; Toshiharu Ninomiya; Jun Hata; Yoichiro Hirakawa; Fumie Ikeda; Masayo Fukuhara; Taeko Hotta; Masafumi Koga; Udai Nakamura; Dongchon Kang; Takanari Kitazono; Yutaka Kiyohara
Journal:  Cardiovasc Diabetol       Date:  2015-06-24       Impact factor: 9.951

6.  Oxidized LDL and Fructosamine Associated with Severity of Coronary Artery Atherosclerosis in Insulin Resistant Pigs Fed a High Fat/High NaCl Diet.

Authors:  Timothy C Nichols; Elizabeth P Merricks; Dwight A Bellinger; Robin A Raymer; Jing Yu; Diana Lam; Gary G Koch; Walker H Busby; David R Clemmons
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

7.  Glycated Albumin Levels in Patients with Type 2 Diabetes Increase Relative to HbA1c with Time.

Authors:  Hye-Jin Yoon; Yong-Ho Lee; Kwang Joon Kim; So Ra Kim; Eun Seok Kang; Bong-Soo Cha; Hyun Chul Lee; Byung-Wan Lee
Journal:  Biomed Res Int       Date:  2015-09-21       Impact factor: 3.411

8.  Glycated albumin and the risk of micro- and macrovascular complications in subjects with type 1 diabetes.

Authors:  Hye-jin Yoon; Yong-ho Lee; So Ra Kim; Tyler Hyungtaek Rim; Eun Young Lee; Eun Seok Kang; Bong-soo Cha; Hyun Chul Lee; Byung-wan Lee
Journal:  Cardiovasc Diabetol       Date:  2015-05-15       Impact factor: 9.951

9.  Development of an HbA1c-based conversion equation for estimating glycated albumin in a Korean population with a wide range of glucose intolerance.

Authors:  Chang Hee Jung; You-Cheol Hwang; Kwang Joon Kim; Bong Soo Cha; Cheol-Young Park; Won Seon Jeon; Jae Hyeon Kim; Sang-Man Jin; Sang Youl Rhee; Jeong-Taek Woo; Byung-Wan Lee
Journal:  PLoS One       Date:  2014-04-22       Impact factor: 3.240

10.  Glycated Albumin for Glycemic Control in T2DM Population: A Multi-Dimensional Evaluation.

Authors:  Lucrezia Ferrario; Fabrizio Schettini; Angelo Avogaro; Chiara Bellia; Federico Bertuzzi; Graziella Bonetti; Antonio Ceriello; Marcello Ciaccio; Massimiliano Corsi Romanelli; Elena Dozio; Luca Falqui; Angela Girelli; Antonio Nicolucci; Gianluca Perseghin; Mario Plebani; Umberto Valentini; Martina Zaninotto; Silvana Castaldi; Emanuela Foglia
Journal:  Clinicoecon Outcomes Res       Date:  2021-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.